(Q46055656)

19 December 2017

title

EGFR mutation analysis in non-small-cell lung cancer : Experience from routine diagnostics (English)

1 reference

19 December 2017

author name string

C Tapia

1

1 reference

19 December 2017

S Savic

2

1 reference

19 December 2017

M Bihl

3

1 reference

19 December 2017

A Rufle

4

1 reference

19 December 2017

I Zlobec

5

1 reference

19 December 2017

L Terracciano

6

1 reference

19 December 2017

L Bubendorf

7

1 reference

19 December 2017

language of work or name

German

0 references

publication date

1 September 2009

1 reference

19 December 2017

published in

Pathologe

1 reference

19 December 2017

volume

30

1 reference

19 December 2017

issue

5

1 reference

19 December 2017

page(s)

384-392

1 reference

19 December 2017

https://scigraph.springernature.com/pub.10.1007/s00292-009-1141-4

exact match

0 references

cites work

Second-generation epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00292-009-1141-4

Molecular predictors of EGFR-TKI sensitivity in advanced non-small cell lung cancer

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00292-009-1141-4

Comprehensive epidermal growth factor receptor gene analysis from cytological specimens of non-small-cell lung cancers

21 January 2018

1 reference

12 December 2020

Mutations of the epidermal growth factor receptor tyrosine kinase domain and associations with clinicopathological features in non-small cell lung cancer patients

1 reference

12 December 2020

Epidemiology, etiology, and prevention of lung cancer

1 reference

12 December 2020

Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancer

1 reference

12 December 2020

Lung adenocarcinoma: guiding EGFR-targeted therapy and beyond

1 reference

12 December 2020

Sequential, alternating, and maintenance/consolidation chemotherapy in advanced non-small cell lung cancer: a review of the literature

1 reference

12 December 2020

Mutational analysis in cytological specimens of advanced lung adenocarcinoma: a sensitive method for molecular diagnosis.

1 reference

12 December 2020

Noncontact laser microdissection and catapulting for pure sample capture

1 reference

12 December 2020

Multiple ras downstream pathways mediate functional repression of the homeobox gene product TTF-1

1 reference

12 December 2020

Clinicopathologic characteristics of the EGFR gene mutation in non-small cell lung cancer

1 reference

12 December 2020

Erlotinib in lung cancer - molecular and clinical predictors of outcome

1 reference

12 December 2020

Challenges of detecting EGFR T790M in gefitinib/erlotinib-resistant tumours

1 reference

12 December 2020

EGFR mutation is specific for terminal respiratory unit type adenocarcinoma

1 reference

12 December 2020

Epidermal growth factor receptor mutations in lung cancer

1 reference

12 December 2020

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

12 December 2020

Epidermal growth factor receptor gene amplification is acquired in association with tumor progression of EGFR-mutated lung cancer.

1 reference

12 December 2020

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

12 December 2020

Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib

1 reference

12 December 2020

EGFR antagonists in cancer treatment

1 reference

12 December 2020

Role of KRAS and EGFR as biomarkers of response to erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21.

1 reference

12 December 2020

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

1 reference

12 December 2020

Impact of EGFR mutation analysis in non-small cell lung cancer.

1 reference

12 December 2020

Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers

1 reference

12 December 2020

Biomarkers of response to epidermal growth factor receptor inhibitors in Non-Small-Cell Lung Cancer Working Group: standardization for use in the clinical trial setting.

1 reference

12 December 2020

Assessing EGFR mutations

1 reference

12 December 2020

Detection of epidermal growth factor receptor gene mutations in cytology specimens from patients with non-small cell lung cancer utilising high-resolution melting amplicon analysis

1 reference

12 December 2020

Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03.

1 reference

12 December 2020

1 reference

12 December 2020

10.1007/S00292-009-1141-4

Identifiers

DOI

1 reference

19 December 2017

1 reference

19 December 2017